HOME >> BIOLOGY >> NEWS
Antibiotic-resistant bacteria increased after clindamycin use for common vaginal infection

se after treatment.

"Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with BV," said Dr. Beigi. "Increased bacterial resistance following clindamycin treatment may account for persistence of some pathogens after therapy."

Dr. Hillier said she believes these study results have the possibility to significantly impact standard BV treatment. "I think any time you find out that use of an antibiotic results in a huge antibiotic resistance, it's important," she said. Treatment decisions, however, remain the province of individual physicians and patients, Dr. Hillier added.

In addition to Drs. Beigi and Hillier, other study authors include Michele Austin, B.S.; Leslie Meyn, M.S.; and Marijane Krohn, Ph.D., all of the University of Pittsburgh. The study was funded by an unrestricted grant from 3M Pharmaceuticals, manufacturer of MetroGel-Vaginal, a metronidazole-containing treatment for bacterial vaginosis, and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.


'"/>


1-Nov-2004


Page: 1 2 3

Related biology news :

1. In limiting life span, study finds booming bacteria innocent
2. Cornell scientists link E. coli bacteria to Crohns disease
3. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
4. Researchers watch antibiotics, bacteria meet at atomic level
5. A new plant-bacterial symbiotic mechanism promising
6. Piecing together the cyanobacteria puzzle
7. New research shows vaginal bacteria vary among healthy women, need customized treatment
8. New way to target and kill antibiotic-resistant bacteria found
9. UCF professor finds bacterial pathogen may be key to understanding cancer development
10. Helping chlorine-eating bacteria clean up toxic waste
11. Researchers discover acquired DNA key to certain bacterial infection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, a leading ... has collaborated with EchoNous Inc. to develop the cloud-based connected health KOSMOS platform ... function, which has been clinically tested versus expert measurements, yielding improved results in ...
(Date:5/28/2020)... ... 2020 , ... Today bioinformatics leader hc1® announced ... lab testing insights and hc1’s exclusive Local Risk Index in a unified CV19 ... employees returning to the workplace. , “Some of the best ways to keep ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, ... their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at ... place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that it has filed an Investigational New Drug application (IND) with ... trial of its lead drug candidate NBTX-001 in patients with panic disorder (PD). ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... release of the NEON Micro-Tracer Solution, a highly accurate, contact tracing ... virus in the workplace. Contact tracing, a core disease control measure, is a ...
(Date:5/30/2020)... ... 2020 , ... Medrio, Inc., the leading provider of eClinical ... Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for conditions like ... in (FPI) in just seven days. The Cytovale technology will allow patients with ...
(Date:5/26/2020)... ... May 26, 2020 , ... Brilliant , the leading smart ... smart garage door openers, announce a new integration to bring more convenience, simplicity, and ... openers powered by Aladdin Connect® can now be controlled from Brilliant’s in-wall touchscreen control ...
Breaking Biology Technology:
Cached News: